🌍✈️ Julia Awarded Santander International Short Stays Scholarship!

We are delighted to announce that Julia has received the Santander International Short Stays Scholarship, awarded by Santander and Johannes Gutenberg University. In May, she took part in an intensive two-week language course in Oxford, with mornings dedicated to presentations and writing, and afternoons focused on vocabulary training. Congratulations, Julia! We’re proud of your achievement!

🎓🎉 Selin succesfully defended her PhD!

We are pleased to share that our Postdoctoral Research Associate, Selin Akpinar Adscheid, has successfully defended her doctoral thesis on July 11, 2025. Selin carried out her PhD research in Biopharmacy and Pharmaceutical Technology as a Marie Skłodowska-Curie Actions PhD Fellow within the Bio2Brain project. Her work was conducted at MyBiotech GmbH in collaboration with … Continued

🧪✨ Open Day 2025

On June 26th, we at the Friedland Lab and the Institute of Pharmaceutical and Biomedical Sciences welcomed many curious prospective students to the JGU Open Day and offered exciting insights into the world of Pharmacology & Toxicology as well as Clinical Pharmacy. We showcased just how diverse and research-driven the Pharmacy Department in Mainz is … Continued

🔬We welcome Sebastian as a new PhD student!

Sebastian began his PhD thesis at the Friedland Research Lab following his earlier experiences with us as a HiWi and placement year student. His research will focus on the role of stress granules and RNA dynamics in Alzheimer’s disease, helping us better understand how cellular stress responses contribute to neurodegeneration. We wish him a wonderful … Continued

📢 We’re Launching: PharmBePsych

At the Friedland Research Lab, we’re excited to share the launch of our new research initiative: PharmBePsych PharmBePsych, led by the Friedland Research Lab, is a groundbreaking clinical research project taking place in community pharmacies across Rhineland-Palatinate, Germany. It aims to strengthen adherence to long-term treatment plans and help prevent relapses in people with mental … Continued

🩸🧠 Blood-Based RNA Modification Studies Underway in Alzheimer’s Research

We are excited to announce the launch of a new phase in our Alzheimer’s research: the start of blood-based studies focusing on the RNA modification Nš-methyladenosine (mšA). Having already identified mšA as a potential early marker of mitochondrial dysfunction in the brain, we are now extending our investigations to blood samples, a key step toward … Continued